Walleye Capital
IDXX icon

Walleye Capital’s Idexx Laboratories IDXX Stock Holding History

Walleye Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-170
Closed -$95.5K – 4934
2026
Q1 		$95.5K Sell
170
-13,261
-99% -$8.5M ﹤0.01% 3692
2025
Q4 		$9.09M Buy
13,431
+13,152
+4,714% +$8.96M 0.03% 728
2025
Q3 		$178K Buy
279
+48
+21% +$29.1K ﹤0.01% 3390
2025
Q2 		$124K Buy
231
+118
+104% +$56.4K ﹤0.01% 3667
2025
Q1 		$47.5K Sell
113
-68
-38% -$29.5K ﹤0.01% 3864
2024
Q4 		$74.8K Sell
181
-30,689
-99% -$13.5M ﹤0.01% 4242
2024
Q3 		$15.6M Buy
30,870
+9,016
+41% +$4.38M 0.03% 449
2024
Q2 		$10.6M Buy
21,854
+14,742
+207% +$7.4M 0.02% 716
2024
Q1 		$3.84M Buy
+7,112
New +$3.89M 0.01% 1498
2023
Q2 		– Sell
-478
Closed -$229K – 4555
2023
Q1 		$239K Sell
478
-4,091
-90% -$1.96M ﹤0.01% 2326
2022
Q4 		$1.86M Buy
+4,569
New +$1.77M 0.03% 626
2021
Q4 		– Sell
-914
Closed -$568K – 2194
2021
Q3 		$568K Buy
+914
New +$614K 0.02% 732

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Walleye Capital's IDXX Position: Q2 2026 in Review

Walleye Capital sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 170 shares — an estimated $95.5K sold.

Walleye Capital first reported a position in IDXX in Q3 2021 and held it in 12 quarters. The position peaked at $15.6M in Q3 2024. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Walleye Capital reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 170 Idexx Laboratories shares in Q2 2026, an estimated $95.5K.
  • Walleye Capital first reported a position in Idexx Laboratories in Q3 2021 and held it in 12 quarters.
  • Walleye Capital's Idexx Laboratories position peaked at $15.6M in Q3 2024.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.